The number of cell and gene therapies entering clinical trials is growing at an increased rate. Having a strong supply chain strategy while understanding the import and export logistics for cell and gene therapies is vital for overcoming the challenges faced in a highly regulated environment.

In this webinar, Marken will discuss the many logistical challenges of cell and gene therapy trials while reaching diverse patient populations.

The different supply chain strategies for cell and gene therapies
How to take your existing logistics to the next level of regulatory compliance
The various challenges faced with importing biological samples
How to navigate the logistical challenges of exporting a clinical drug product
Optimizing geographical footprint by utilizing Direct-to-Patient (DTP) distribution best practices
The importance of remaining ISO, GDP and GMP compliant

Keywords:

Speaker

Bengt-Simon Feth, Global Senior Director, Cell and Gene Operations, Marken

Bengt-Simon Feth is the Global Senior Director, Cell and Gene Operations, for Marken. Simon has spent eight years at Marken growing global operations for Direct-to-Patient, Clinical Trial Distribution and Cell and Gene Therapy. Simon has over 15 years of experience working in the supply chain and pharmaceutical industries and is a graduate of Provadis Hochschule in Frankfurt, Germany.

Message Presenter

Who Should Attend?

Senior professionals who are involved with:

Pharmaceutical companies
Biotechnology companies
Central labs
CMOs
CROs
CDMOs

What You Will Learn

In this webinar, participants will learn about:

The different supply chain strategies for cell and gene therapies
How to take your existing logistics to the next level of regulatory compliance
The various challenges faced with importing biological samples
How to navigate the logistical challenges of exporting a clinical drug product
Optimizing geographical footprint by utilizing Direct-to-Patient (DTP) distribution best practices
The importance of remaining ISO, GDP and GMP compliant

Xtalks Partner

Marken

Marken is a wholly owned subsidiary of the UPS Healthcare Division. With Polar Speed and Marken included, the UPS division staffs 128 locations with 5,500 employees worldwide. Marken maintains the leading position for Direct-to-Patient and Home Healthcare Services, biological sample shipments and offers a state-of-the-art GMP-compliant depot network and logistics hubs in 58 locations worldwide for clinical trial material storage and distribution. Marken’s dedicated 1,900+ staff members manage 120,000 drug and biological shipments every month at all temperature ranges in more than 220 countries. Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry.